Q4 2024 Earnings Call Transcript March 20, 2025 Cognition Therapeutics, Inc. misses on earnings expectations. Reported EPS is ...

Lisa Ricciardi; President, Chief Executive Officer, Director; Cognition Therapeutics Inc. John Doyle; Chief Fi ...

Q4 2024 Earnings Call Transcript March 13, 2025 REGENXBIO Inc. beats earnings expectations. Reported EPS is $-1.01, ...

Regenxbio Inc (RGNX) showcases robust financial positioning and strategic progress in gene therapy, despite challenges in ...

Q4 2024 Earnings Conference Call March 24, 2025 8:30 AM ETCompany ParticipantsGreg Robles - IRGarrett Smallwood - Chairman ...

Welcome everyone to the Fourth Quarter and Year End 2024 REGENXBIO Earnings Conference Call. At this time ... dystrophy and AbbVie RGX-314 for wet AMD. We are in a strong position as we prepare ...

Good morning, and welcome to Ocugen's fourth quarter and full-year 2024 financial results and business update. Please note that this call is being ... degeneration, wet AMD, with its unique ...

Ladies and gentlemen, good day, and welcome to the Yatsen fourth quarter and full-year 2024 earnings conference call. Today's conference call is being recorded. At this time, I would like to turn ...

Welcome to Sleep Number's Q4 ... call and we'll share more about her background, perspectives on Sleep Number, and the path forward. During today's call, I'll share highlights of our 2024 ...